A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Apr, 6 2026
Feb, 2 2024
Jun, 4 2026
Nov, 28 2025
Jan, 21 2026